Xylem (NYSE:XYL) Stock Gets Price Target Reduction from Stifel Nicolaus

Xylem (NYSE:XYL) had its target price reduced by Stifel Nicolaus from $141.00 to $114.00 in a report issued on Wednesday,Benzinga reports. They currently have a buy rating on the industrial products company’s stock.

Other equities research analysts also recently issued research reports about the company. Mizuho set a $99.00 target price on Xylem in a report on Wednesday. Jefferies Financial Group lifted their target price on Xylem from $145.00 to $150.00 and gave the company a “buy” rating in a report on Monday, August 24th. Citigroup decreased their price objective on shares of Xylem from $172.00 to $148.00 and set a “buy” rating for the company in a research note on Monday, October 12th. Robert W. Baird set a $123.00 price target on Xylem in a report on Wednesday. Finally, The Goldman Sachs Group lowered their target price on shares of Xylem from $160.00 to $138.00 and set a “buy” rating on the stock in a research report on Wednesday. Nine analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $121.31.

Xylem Trading Up 1.8%

NYSE:XYL opened at $92.41 on Wednesday. Xylem has a 52 week low of $87.40 and a 52 week high of $152.43. The company’s 50 day moving average price is $105.05 and its 200-day moving average price is $117.57. The company has a quick ratio of 1.24, a current ratio of 1.39 and a debt-to-equity ratio of 0.23. The stock has a market cap of $21.19 billion, a price-to-earnings ratio of 20.44, a PEG ratio of 1.51 and a beta of 1.00.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing the consensus estimate of $1.45 by ($0.01). Xylem had a return on equity of 12.06% and a net margin of 11.94%. The business had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.28 billion. During the same quarter in the prior year, the business earned $1.37 EPS. The company’s revenue was down 3.0% compared to the same quarter last year. On average, equities research analysts forecast that Xylem will post 5.45 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th were paid a dividend of $0.43 per share. The ex-dividend date was Thursday, August 27th. This represents a $1.72 annualized dividend and a dividend yield of 1.9%. Xylem’s dividend payout ratio is 40.95%.

Insider Activity at Xylem

In other news, Director D Koch acquired 11,000 shares of the stock in a transaction dated Thursday, October 29th. The shares were acquired at an average cost of $89.60 per share, for a total transaction of $985,600.00. Following the completion of the transaction, the director owned 12,247 shares in the company, valued at approximately $1,097,331.20. This trade represents a 882.12% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.32% of the company’s stock.

Institutional Trading of Xylem

Several institutional investors have recently modified their holdings of XYL. XXEC Inc. bought a new stake in Xylem in the second quarter valued at $850,841,000. BlackRock Inc. bought a new position in shares of Xylem in the second quarter worth $2,959,730,000. State Street Corp increased its stake in Xylem by 2.4% in the second quarter. State Street Corp now owns 11,444,669 shares of the industrial products company’s stock valued at $1,352,874,000 after acquiring an additional 270,972 shares during the last quarter. Swedbank AB lifted its position in Xylem by 0.3% in the 1st quarter. Swedbank AB now owns 5,526,725 shares of the industrial products company’s stock worth $660,444,000 after buying an additional 18,759 shares during the last quarter. Finally, Royal Bank of Canada grew its position in Xylem by 1.1% during the 1st quarter. Royal Bank of Canada now owns 4,763,241 shares of the industrial products company’s stock worth $569,207,000 after acquiring an additional 53,210 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

Xylem News Summary

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Director D. Christian Koch purchased 11,000 Xylem shares for approximately $985,600 at an average price of $89.60. The transaction increased his direct holdings more than eightfold and may signal confidence that the recent selloff has created an attractive entry point. Insider purchase report
• Positive Sentiment: Some analysts continue to see longer-term value. RBC Capital reaffirmed its buy rating, while RBC’s new coverage assigned a moderate-buy rating and a $125 price target, implying substantial upside from recent levels. RBC rating report
• Neutral Sentiment: Xylem announced divestitures and a new three-segment operating structure. The changes could sharpen strategic focus and improve portfolio efficiency, but execution and transition risks remain. Xylem restructuring report
• Negative Sentiment: Xylem’s latest quarter missed expectations: EPS was $1.44 versus $1.45 expected, revenue was $2.20 billion versus $2.28 billion expected, and sales declined 3% year over year. Management’s new 2026 adjusted-EPS ceiling of $5.45 is below the prior $5.55 floor, reinforcing concerns about weaker growth.
• Negative Sentiment: Barclays downgraded Xylem to equal weight from overweight, JPMorgan lowered its rating to underweight, and UBS, Stifel, BNP Paribas Exane, Citigroup and Oppenheimer reduced price targets. The revisions reflect diminished near-term earnings and valuation expectations. Barclays downgrade report
• Negative Sentiment: Levi & Korsinsky announced an investigation into potential securities-law violations related to investor losses, adding legal uncertainty and another possible overhang for XYL shareholders. Investigation announcement

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.